Author:
La Fauci Giusy,Soldà Giorgia,Di Valerio Zeno,Salussolia Aurelia,Montalti Marco,Scognamiglio Francesca,Capodici Angelo,Fantini Maria Pia,Larson Heidi J.,Leask Julie,Gori Davide,Lenzi Jacopo
Abstract
Abstract
Introduction
The World Health Organization defines rotavirus as among the most severe causes of viral gastroenteritis affecting children under 5 year old. Italy and other European countries do not release disaggregated data on rotavirus vaccination coverage. This study aimed to assess the uptake and drivers of rotavirus vaccination in Italy.
Methods
We administered a survey to 10,000 Italian citizens recruited via an online panel and proportionate to key demographic strata. We examined rotavirus vaccine uptake among parents whose youngest child was aged 6 weeks to 4 years, their sociodemographic characteristics, their beliefs about vaccine administration, and who recommended the rotavirus vaccination.
Results
A total of 711 respondents met the inclusion criteria for the rotavirus vaccine questionnaire. The uptake was estimated at 60.3% nationwide (66.4% among mothers and 50.2% among fathers). Being a mother and living in cities/suburbs was significantly associated with a higher likelihood of vaccine uptake, while fathers were more likely to be uncertain of their children’s vaccine status. Living in Central Italy and having friends/relatives opposed to vaccination were found to be significantly associated with a lower likelihood of vaccine uptake, while parents’ education level and children’s demographics were not found to correlate with any outcomes. In 90.3% of cases, the rotavirus vaccination was recalled as being recommended by a paediatrician.
Conclusions
Consistent collection of behavioural preferences and socioeconomic characteristics of recipients of rotavirus vaccine campaigns, their epidemiological information, cost-benefit, and national policy data are crucial for designing effective vaccination strategies in Italy and other European countries with similar social profiles to reach the target uptake.
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. World Health Organization. Rotavirus. https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications/vaccine-standardization/rotavirus. Accessed 12 September 2023.
2. EpiCentro. Rotavirus. https://www.epicentro.iss.it/rotavirus/epidemiologia. Accessed 12 September 2023.
3. Aliabadi N, Antoni S, Mwenda JM, Weldegebriel G, Biey JN, Cheikh D, et al. Global impact of rotavirus vaccine introduction on rotavirus hospitalisations among children under 5 years of age, 2008–16: findings from the global Rotavirus Surveillance Network. Lancet Global Health. 2019;7(7). https://doi.org/10.1016/s2214-109x(19)30207-4.
4. World Health Organization. Rotavirus vaccines: WHO position paper– July 2021. https://www.who.int/teams/immunization-vaccines-and-biologicals/diseases/rotavirus. Accessed 12 September 2023.
5. Of AJOB, Cohen R, Martinón-Torres F, Posiuniene I, Benninghoff B, Oh KB, et al. The value of Rotavirus Vaccination in Europe: a call for action. Infect Dis Ther. 2023;12:9–29.